Skip to content
drillr.ai
Sign up

002287.SZ

Tibet Cheezheng Tibetan Medicine Co., Ltd.

SZSE · Healthcare · C 制造业 · CN

CNY 18.79
−0.21%
Ask drillr

  • Oct 23, 2026, 10:53 UTC

    Tibet Cheezheng Tibetan Medicine plans to inject RMB 300 million in cash into its wholly owned subsidiary Beijing Cheezheng Pharmaceutical Technology, increasing its registered capital from RMB 80 million to RMB 380 million while retaining 100% ownership.

    Source:

  • Oct 23, 2026, 10:49 UTC

    Qizheng Tibetan Medicine reported revenue of 1.34 billion yuan and net profit of 407 million yuan for the first three quarters of 2026.

    Source:

  • Oct 23, 2026, 10:49 UTC

    Qizheng Tibetan Medicine reported third-quarter 2026 revenue of 362 million yuan, up 4.01% year over year, and net profit of 35.7863 million yuan, down 45.05%.

    Source:

  • Sep 17, 2026, 09:03 UTC

    Qizheng Group, controlling shareholder of Tibet Cheezheng Tibetan Medicine, pledged 6.8 million company shares to Bank of Huaxia Lanzhou Branch for production and operations.

    Source:

  • Aug 21, 2026, 10:07 UTC

    Cheezheng Tibetan Medicine proposed a cash dividend of 2.30 yuan per 10 shares (tax inclusive) based on 567 million shares excluding repurchased shares, with no bonus shares or capital reserve conversion.

    Source: